#

Vazhnoe

: 623
GMR specializes in emergency medical care / Photo: GMR
News·
GMR IPO: emergency ambulance service provider goes public
The combined value of chip companies with a market capitalization of more than $10 billion has risen 26% since the start of the war with Iran - FT / Photo: Lightsaber Collection / Unsplash.com
Review·
Where to invest $10,000: three stocks that could benefit from $1 trillion in AI spending
Michael Burry compared himself to the boy who cried wolf but no one listened to him / Photo: Astrid Stawiarz/Getty Images
News·
'Minutes before a bloody car crash': Burry predicted a new stock market crash
Founded in 2021, Odyssey is developing therapies to treat patients with autoimmune diseases like ulcerative colitis, Crohn’s disease, and lupus / Photo: Odyssey Therapeutics
Small Caps·
Odyssey IPO: Immune system biotech debuts on the Nasdaq
Mobia Medicals development - Vivistim device for vagus nerve stimulation / Photo: Vivistim.com
News·
Mobia Medical IPO: developer of stroke rehabilitation systems goes public
HawkEye 360, a provider of satellite-based signals intelligence for U.S. government agencies, has gone public in a deal priced at the top of the marketed range / Photo: X / HawkEye 360
Small Caps·
HawkEye 360 IPO: Surveillance firm debuts on the NYSE
Suja Life plans to use the proceeds from the share placement for brand marketing / Photo: Suja Life
News·
Suja Life IPO: shares in the juice maker have become available. It is a competitor of Coca-Cola
Axios quoted sources as saying: the US and Iran are close to a peace agreement / Photo: Vibe Images / Shutterstock
News·
Oil prices dip below $100 amid hopes of a deal between the U.S. and Iran
AI solutions provider for collecting and analyzing large sets of disparate data (Big Data) Palantir is poised to surpass Nvidia in long-term sales growth / Photo: rblfmr/Shutterstock.com
News·
US employment, Palantir and Novo earnings: what investors need to know this week
Photo: Tigarto / Shutterstock.com
News·
"Woodstock for capitalists" without Buffett: how Berkshire's shareholder meeting went down
Hemab is developing therapies for blood coagulation disorders such as Glanzmann thrombasthenia and Von Willebrand Disease, according to its filings / Photo: Hemab Therapeutics
Small Caps·
+1
·
Hemab IPO: Novo-backed blood disorder biotech debuts on the Nasdaq
Seaport Therapeutics shares become available / Photo: Seaport Therapeutics
News·
IPO of Seaport Therapeutics: shares of the antidepressant developer become available
Load more